"saxagliptin" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-gliptin",
        "t2": "dipeptidyl aminopeptidase-IV inhibitor"
      },
      "expansion": "[Term?] + -gliptin (“dipeptidyl aminopeptidase-IV inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -gliptin (“dipeptidyl aminopeptidase-IV inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "saxagliptin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -gliptin",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze."
      ],
      "id": "en-saxagliptin-en-noun-mVY64GxO",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "hypoglycemic",
          "hypoglycemic"
        ],
        [
          "drug",
          "drug"
        ],
        [
          "orally",
          "orally"
        ],
        [
          "hydrate",
          "hydrate"
        ],
        [
          "degradation",
          "degradation"
        ],
        [
          "incretin",
          "incretin"
        ],
        [
          "insulin",
          "insulin"
        ],
        [
          "pancreas",
          "pancreas"
        ],
        [
          "Onglyza",
          "Onglyza"
        ],
        [
          "metformin",
          "metformin"
        ],
        [
          "Kombiglyze",
          "Kombiglyze"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "saxagliptin"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌsæk.səˈɡlɪp.tɪn/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "saxagliptin"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-gliptin",
        "t2": "dipeptidyl aminopeptidase-IV inhibitor"
      },
      "expansion": "[Term?] + -gliptin (“dipeptidyl aminopeptidase-IV inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -gliptin (“dipeptidyl aminopeptidase-IV inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "saxagliptin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English term requests",
        "English terms suffixed with -gliptin",
        "English uncountable nouns",
        "Pages with 1 entry",
        "Pages with entries",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "hypoglycemic",
          "hypoglycemic"
        ],
        [
          "drug",
          "drug"
        ],
        [
          "orally",
          "orally"
        ],
        [
          "hydrate",
          "hydrate"
        ],
        [
          "degradation",
          "degradation"
        ],
        [
          "incretin",
          "incretin"
        ],
        [
          "insulin",
          "insulin"
        ],
        [
          "pancreas",
          "pancreas"
        ],
        [
          "Onglyza",
          "Onglyza"
        ],
        [
          "metformin",
          "metformin"
        ],
        [
          "Kombiglyze",
          "Kombiglyze"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "saxagliptin"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌsæk.səˈɡlɪp.tɪn/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "saxagliptin"
}